Capricor Therapeutics | CAPR - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Bioline Rx USD -977K 2.96M 2025-09
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cipla INR 7.49B 4.2B 2026-03
Cytokinetics USD -206.03M 23M 2026-03
Geron USD -3.64M 27.5M 2026-03
Grifols EUR 257.85M 190.87M 2024-12
Immunic USD -19.3M 6.28M 2025-12
J&J USD 7.82B 2.86B 2026-03
Plus Therapeutics USD -5.71M 1.29M 2025-12
Prothena USD -21.58M 15.33M 2025-12
PTC Therapeutics USD -2.46M 136.62M 2026-03
Sarepta Therapeutics USD 343.17M 750.85M 2026-03